See the presentations of the Bolivia Sessions 2017

We thank all the speakers of the Bolivia Sessions2017 who shared their presentations to contribute to our mission of promoting Interventional Cardiology in Latin America. See them below   Agatiello, Carla: “Como iniciar un programa TAVI en Latinoamérica”.     Arregui, Elizabeth: “Estenosis aórtica: candidatos para TAVI”.     Bello, Fernando: “Enfermedad carotídea: Tratamiento quirúrgico”.  <a href="https://solaci.org/en/2017/01/19/see-the-presentations-of-the-bolivia-sessions-2017/" title="Read more" >...</a>

TAVR vs. Surgery: Valve Performance at Five Years (PARTNER I)

The aim of this study was to evaluate the long-term performance of transcatheter aortic valve replacement (TAVR) and surgically-implanted valves through longitudinal echocardiographic follow-up of the PARTNER I trial patients.   The study included all patients receiving TAVR or undergoing surgery who had a post-implant echocardiogram at five years analyzed for peak systolic velocity, mean gradient,<a href="https://solaci.org/en/2017/01/13/tavr-vs-surgery-valve-performance-at-five-years-partner-i/" title="Read more" >...</a>

Post TAVR Cognitive Function at Short Term: Better or Worse?

There is little information on the short and mid-term evolution of cognitive function after transcatheter aortic valve replacement (TAVR).   The aim of this study was to describe global changes in cognitive function and changes in specific cognitive domains one year after TAVR.   Fifty one patients undergoing TAVR, median age 80, were prospectively followed<a href="https://solaci.org/en/2017/01/11/post-tavr-cognitive-function-at-short-term-better-or-worse/" title="Read more" >...</a>

See the Presentations of the 2016 Chile Sessions

We thank all the speakers of the Chile 2016 Sessions who shared their presentations to contribute to our mission of promoting the dissemination of information from research and clinical practice in Interventional Cardiology. You can read and/or download them below   Lluberas, Ricardo. “Role of pharmacovasive therapy in the treatment of IAMcEST. Implications for Latin<a href="https://solaci.org/en/2017/01/07/see-the-presentations-of-the-2016-chile-sessions/" title="Read more" >...</a>

TAVR in Low-Flow Low-Gradient Aortic Stenosis and Severe Impairment of Systolic Function

Patients with low-flow, low-gradient severe symptomatic aortic stenosis associated with severe impairment of the left ventricular systolic function have shown acceptable outcomes after transcatheter aortic valve replacement (TAVR), according to the multicenter TOPAS-TAVI registry, which demonstrated a relatively low 30-day mortality rate.   Considering the very high risk presented by this population involved, a 30-day<a href="https://solaci.org/en/2017/01/06/tavr-in-low-flow-low-gradient-aortic-stenosis-and-severe-impairment-of-systolic-function/" title="Read more" >...</a>

Coronary Lesions After TAVR: Severity May Be Modified

Courtesy of Dr. Carlos Fava. Between 40% and 70% of patients undergoing transcatheter aortic valve replacement (TAVR) present coronary lesions. The fact that aortic stenosis affects how blockages act, and that, after stenosis correction, hemodynamic compromise for those same lesions may vary, has been consistently proven. Its management has not been determined yet.   The study<a href="https://solaci.org/en/2016/12/13/coronary-lesions-after-tavr-severity-may-be-modified/" title="Read more" >...</a>

TAVR: Pre-Existing Complete Right Bundle Branch Block Is Associated with Mortality

Courtesy of Dr. Carlos Fava. The fact that the presence of a complete right bundle branch block (RBBB) increases the risk of bradycardia, high-grade atrioventricular block, and need for a permanent pacemaker (PPM) after TAVR is well-known.   The impact of pre-existing complete right bundle branch block has not been well-studied.    This article analyses 749 patients enrolled in<a href="https://solaci.org/en/2016/12/05/tavr-pre-existing-complete-right-bundle-branch-block-is-associated-with-mortality/" title="Read more" >...</a>

Cerebral Protection in TAVR: Studies Presented at London Valves

SENTINEL One of the new devices assessed at London Valves was Sentinel, which is made up of two independent filters. The larger filter is deployed in the brachiocephalic trunk, and the smaller filter is deployed in the left common carotid artery. The study included 22 patients and the device was deployed successfully in 20 of them<a href="https://solaci.org/en/2016/10/20/cerebral-protection-in-tavr-studies-presented-at-london-valves/" title="Read more" >...</a>

Martínez Ríos: “SOLACI Went from a Dream to a World-Renowned Society”

Dr. Marco Antonio Martínez Ríos comes from a family of physicians. “Studying Medicine was the most natural thing in the world for me,” admits Martínez Ríos, who in 1993 became president of the Latin American Group of Interventional Cardiology (Grupo Latinoamericano de Cardiología Intervencionista, GLACI), the seed that would grow to become SOLACI in 1994.  <a href="https://solaci.org/en/2016/09/27/martinez-rios-solaci-went-from-a-dream-to-a-world-renowned-society/" title="Read more" >...</a>

Hugo Londero: “The arrival of interventional cardiology has changed many physicians’ personalities”.

He grew up in the 40s, surrounded by cap screws, dental crowns and damp from the Paraná River. His father, mother and two brothers, were dentists. Years later, his daughter and niece would also become dentists. But since his early years, Hugo Londero had known he would become a physician. He was certain his greatest<a href="https://solaci.org/en/2016/08/02/hugo-londero-the-arrival-of-interventional-cardiology-has-changed-many-physicians-personalities/" title="Read more" >...</a>